ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Poster session 5: Ubiquitous effects of obesity and the metabolic syndrome
Tue 30 Aug 08:30 - 12:30 Overweight, obesity and central obesity Poster Session Posters - Poster Zone C

Abstract Slides/e-posters Video Report

List of Presentations

Related documents
08:30P4097Has an abnormal lipid profile the same impact in obese patients compared to non-obese patients?Ana Teresa TIMOTEO (Lisboa, PT)
08:30P4098What is the real impact of obesity in coronary heart disease?Bruno Cordeiro PICARRA (Elvas, PT)
08:30P4099Screening for coronary artery disease in asymptomatic obese patients with erectile dysfunctionNikolaos IOAKIMIDIS (Athens, GR)
08:30P4100Non-invasive detection of vascular dysfunction in sleep apnea syndrome by cardio-ankle vascular index and flow-mediated dilatationAkiomi YOSHIHISA (Fukushima, JP)
08:30P4101Do meausures of arterial function and atherosclerotic burden add incremental benefit to Framingham risk alone in predicting outcome in obese patients?Thomas H MARWICK (Hobart, AU)
08:30P4102Weight loss effect on adiponectin and hs-CRP levels in patients with metabolic syndromeIoannis EFTHIMIADIS (Thessaloniki, GR)
08:30P4103Low levels of IgM antibodies against phosphorylcholine (anti-pc) are related to abdominal obesity and impaired fibrinolysis in the elderlyKnut PETTERSSON (Solna, SE)
08:30P4104Obesity and cardiovascular disease (CVD): an association or a cause and effect relationship?Mahfouz EL SHAHAWY (Sarasota, US)
08:30P4105Effect of an FTO polymorphism on overweight and obesity in the polish WOBASZ study - the preliminary results.Aleksandra PIWONSKA (Warszawa, PL)
08:30P4106Significant cardiovascular risk factor burden seen in young, asymptomatic, and physically active subjects with a normal and elevated adjusted Asian body mass index.Glenn Kay Mun LEE (Singapore, SG)
08:30P4107Rapid increase in abdominal obesity and deteriorating cardiometabolic risk profile in Poland - LIPIDOGRAM 2004 and 2006 nation-wide surveys of 32,683 individualsBernhard Michael KAESS (Regensburg, DE)
08:30P4108Reducing cardiovascular risk factors in an obese population - preliminary findings from a community based cardiovascular disease prevention programme in IrelandIrene GIBSON (Galway, IE)
08:30P4109Metabolic syndrome predicts incidence of coronary artery disease but not stroke in essential hypertensive subjects: Data from a Greek 6-year-follow-up studyCostas TSIOUFIS (Athens, GR)
08:30P4110Identification of ARIA as novel factor in the pathophysiology of metabolic syndromeYoshiki AKAKABE (Kyoto, JP)
08:30P4111Association of metabolic syndrome and arterial stiffness with angiographic coronary artery diseaseAris BECHLIOULIS (Ioannina, GR)
08:30P4112Impact of metabolic syndrome on functional recovery after cardiac rehabilitationNicola RUSSO (Padova, IT)
08:30P4113Predictive accuracy of metabolic syndrome definitions for the coronary artery diseaseBiljana PARAPID (Beograd, RS)
08:30P4114Is height an independent marker of metabolic syndrome in a developing society? A cross-sectional study of 22,180 Chilean adults.Elard KOCH (Santiago, CL)
08:30P4115Respective contributions of traditional cardiovascular risk factors and metabolic syndrome in the prediction of coronary heart diseaseVanina BONGARD (Toulouse Cedex 9, FR)
08:30P4116Blood pressure variability and subclinical organ damage in metabolic syndromeSilviu Ionel DUMITRESCU (Bucharest, RO)
08:30P4117Aerobic capacity and endothelial function in patients with metabolic syndromeJose MANFREDI (Montevideo, UY)